Publication Cover
New Genetics and Society
Critical Studies of Contemporary Biosciences
Volume 41, 2022 - Issue 2
694
Views
0
CrossRef citations to date
0
Altmetric
Articles

Exploring “quality” in cord blood transfusion: uncertainties, bionetworks, and collaborations

ORCID Icon, ORCID Icon, & ORCID Icon
Pages 136-156 | Received 25 Jan 2021, Accepted 05 May 2022, Published online: 26 May 2022

References

  • Abbott, A. 1988. The System of Professions: An Essay on the Division of Expert Labour. London, UK: The University of Chicago Press.
  • All-Party Parliamentary Group on Stem Cell Transplantation. 2012. “Cord Blood Transplantation: Meeting the Unmet Demand.” http://www.appg-stemcell.org.uk/uploads/4/4/4/7/44471153/cord_blood_transplantation_-_meeting_the_unmet_demand.pdf.
  • Ballen, K., B. Logan, M. Laughlin, W. He, D. Ambruso, S. Armitage, R. Beddard, et al. 2015. “Effect of Cord Blood Processing on Transplantation Outcomes After Single Myeloablative Umbilical Cord Blood Transplantation.” Biology of Blood and Marrow Transplantation 21 (4): 688–695. doi:10.1016/j.bbmt.2014.12.017.
  • Barker, J., C. Byam, and A. Scaradavou. 2011. “How I Treat: The Selection and Acquisition of Unrelated Cord Blood Grafts.” Blood 117 (8): 2332–2339. doi:10.1182/blood-2010-04-280966.
  • Beltrame, L. 2020a. “Anchoring Hopes in a Regime of Truth. The Legitimizing Use of Cord Blood-Derived Products in Italy.” New Genetics and Society 39 (2): 173–190. doi:10.1080/14636778.2019.1686969.
  • Beltrame, L. 2020b. “Values in Tension. Clinical Quality and Civic Participation in Umbilical Cord Blood Banking in Italy.” Sociology of Health and Illness 42 (4): 689–704. doi:10.1111/1467-9566.13049.
  • Braun, V., and V. Clarke. 2006. “Using Thematic Analysis in Psychology.” Qualitative Research in Psychology 3 (2): 77–101. doi:10.1191/1478088706qp063oa.
  • Brown, N., L. L. Machin, and D. McLeod. 2011. “Immunitary Bioeconomy: The Economisation of Life in the International Cord Blood Market.” Social Science and Medicine 72 (7): 1115–1122. doi:10.1016/j.socscimed.2011.01.024.
  • Brown, N., and R. Williams. 2015. ““Cord Blood Banking-Bio-Objects on the Borderlands Between Community and Immunity.” Life Sciences, Society and Policy 11 (11): 1–18. doi:10.1186/s40504-015-0029-8.
  • Cambrosio, A., P. Keating, T. Schlich, and G. Weisz. 2006. “Regulatory Objectivity and the Generation and Management of Evidence in Medicine.” Social Science and Medicine 63 (1): 189–199. doi:10.1016/j.socscimed.2005.12.007.
  • Chang, H. C. 2016. “The Multiple Roles of Cord Blood Banks in Taiwan: Competition and Collaboration.” New Genetics and Society 25 (3): 1–21. doi:10.1080/14636778.2016.1209106.
  • Covaleski, M. A., M. W. Dirsmith, and L. Rittenberg. 2003. “Jurisdictional Disputes Over Professional Work: The Institutionalization of the Global Knowledge Expert.” Accounting Organizations and Society 28 (4): 323–355. doi:10.1016/S0361-3682(02)00029-6.
  • D’Amour, D., M. Ferrada-Videla, L. S. M. Rodriguez, and M. D. Beaulieu. 2005. “The Conceptual Basis for Interprofessional Collaboration: Core Concepts and Theoretical Frameworks.” Journal of Interprofessional Care 19 (Suppl. 1): 116–131. doi:10.1080/13561820500082529.
  • Dehn, J., S. Spellman, C. Hurley, B. Shaw, J. Barker, L. Burns, D. Confer, et al. 2019. “Selection of Unrelated Donors and Cord Blood Units for Hematopoietic Cell Transplantation: Guidelines from the NMDP/CIBMTR.” Blood 134 (12): 924–934. doi:10.1182/blood.2019001212.
  • Dessels, C., M. Alessandrini, and M. Pepper. 2018. “Factors Influencing the Umbilical Cord Blood Stem Cell Industry: An Evolving Treatment Landscape.” Stem Cells Translational Medicine 7 (9): 643–650. doi:10.1002/sctm.17-0244.
  • Eapen, M., J. P. Klein, G. F. Sanz, S. Spellman, A. Ruggeri, C. Anasetti, M. Brown, et al. 2011. “Effect of Donor-Recipient HLA Matching at HLA A, B, C, and DRB1 on Outcomes After Umbilical-Cord Blood Transplantation for Leukaemia and Myelodysplastic Syndrome: A Retrospective Analysis.” The Lancet Oncology 12 (13): 1214–1221. doi:10.1016/S1470-2045(11)70260-1.
  • Freeth, D. 2001. “Sustaining Interprofessional Collaboration.” Journal of Interprofessional Care 15: 37–46. doi:10.1080/13561820020022864.
  • Fukushima, M. 2016. “Constructing Failure in Big Biology: The Socio-Technical Anatomy of Japan’s Protein 3000 Project.” Social Studies of Science 46 (1): 7–33. doi:10.1177/0306312715612146.
  • Gachoud, D., M. Albert, A. Kuper, L. Stroud, and S. Reeves. 2012. “Meanings and Perceptions of Patient-Centeredness in Social Work, Nursing and Medicine: A Comparative Study.” Journal of Interprofessional Care 26: 484–490. doi:10.3109/13561820.2012.717553.
  • Gieryn, T. F. 1983. “Boundary-Work and the Demarcation of Science from Non-Science: Strains and Interests in Professional Ideologies of Scientists.” American Sociological Review 48 (6): 781–795. doi:10.2307/2095325.
  • Gluckman, E., H. Broxmeyer, A. Auerbach, H. Friedman, G. Douglas, A. Devergie, H. Esperou, D. Thierry, G. Socie, and P. Lehn. 1989. “Hematopoietic Reconstitution in a Patient with Fanconi’s Anemia by Means of Umbilical-Cord Blood from an HLA-Identical Sibling.” New England Journal of Medicine 321 (17): 1174–1178. doi:10.1056/NEJM198910263211707.
  • Hardey, M., S. Payne, J. Powell, S. Hawker, and C. Kerr. 2001. “Professional Territories and the Fragmented Landscape of Elderly Care.” Journal of the Royal Society for the Promotion of Health 121 (3): 159–164. doi:10.1177/146642400112100312.
  • Heldal, F. 2010. “Multidisciplinary Collaboration as a Loosely Coupled System: Integrating and Blocking Professional Boundaries with Objects.” Journal of Interprofessional Care 24: 19–30. doi:10.3109/13561820903078322.
  • Holstein, J., and J. Gubrium. 1995. The Active Interview. London: SAGE Publications. doi:10.4135/9781412986120
  • Hough, R., R. Danby, N. Russell, D. Marks, P. Veys, B. Shaw, R. Wynn, et al. 2016. “Recommendations for a Standard UK Approach to Incorporating Umbilical Cord Blood Into Clinical Transplantation Practice: An Update on Cord Blood Unit Selection, Donor Selection Algorithms and Conditioning Protocols.” British Journal of Haematology 172 (3): 360–370. doi:10.1111/bjh.13802.
  • Indrayan, A. 2020. “Aleatory and Epistemic Uncertainties Can Completely Derail Medical Research Results.” Journal of Postgraduate Medicine 66 (2): 94–98. doi:10.4103/jpgm.JPGM_585_19.
  • Jaime-Pérez, J., R. Monreal-Robles, L. N. Rodríguez-Romo, C. Mancías-Guerra, J. L. Herrera-Garza, and D. Gómez-Almaguer. 2011. “Evaluation of Volume and Total Nucleated Cell Count as Cord Blood Selection Parameters: A Receiver Operating Characteristic Curve Modeling Approach.” American Journal of Clinical Pathology 136 (5): 721–726. doi:10.1309/AJCPFB6EXO7BJVLR.
  • Japanese Red Cross Society. 2021. “Cord Blood Bank Total.” https://www.bs.jrc.or.jp/bmdc/cordblooddonor/m3_04_statistics.html.
  • Kindwall-Keller, T., and K. Ballen. 2020. “Umbilical Cord Blood: The Promise and the Uncertainty.” Stem Cells Translational Medicine 9 (10): 1153–1162. doi:10.1002/sctm.19-0288.
  • Langan-Fox, J., and C. L. Cooper. 2014. Boundary-Spanning in Organizations: Network, Influence, and Conflict. New York, NY: Routledge.
  • Lippi, G., K. Becan-McBride, D. Behúlová, R. A. Bowen, S. Church, J. Delanghe, K. Grankvist, et al. 2013. “Preanalytical Quality Improvement: In Quality We Trust.” Clinical Chemistry of Laboratory Medicine 51 (1): 229–241. doi:10.1515/cclm-2012-0597.
  • Machin, L. L. 2016. “The Collection of ‘Quality’ Umbilical Cord Blood for Stem Cell Treatments: Conflicts, Compromises, and Clinical Pragmatism.” New Genetics and Society 35 (3): 307–326. doi:10.1080/14636778.2016.1209109.
  • Machin, L. L., N. Brown, and D. McLeod. 2012. “‘Two’s Company – Three’s a Crowd’: The Collection of Umbilical Cord Blood for Commercial Stem Cell Banks in England and the Midwifery Profession.” Midwifery 28 (3): 358–365. doi:10.1016/j.midw.2011.05.002.
  • Machin, L. L., and R. A. Williams. 2017. Interprofessional Spanning and Building Boundaries When Supporting Potential Embryo Donors to Stem Cell Research.” Journal of Interprofessional Care 31 (3): 342–350. doi:10.1080/13561820.2016.1253546.
  • Martin, P., N. Brown, and A. Turner. 2008. “Capitalising Hope: The Commercial Development of Umbilical Cord Blood Stem Cell Banking.” New Genetics and Society 27 (2): 127–143. doi:10.1080/14636770802077074.
  • Moreira, T., C. May, and J. Bond. 2009. “Regulatory Objectivity in Action: Mild Cognitive Impairment and the Collective Production of Uncertainty.” Social Studies of Science 39 (5): 665–690. doi:10.1177/0306312709103481.
  • Moreira, T., and P. Palladino. 2005. “Between Truth and Hope: On Parkinson’s Disease, Neurotransplantation and the Production of the ‘Self’.” History of the Human Sciences 18: 55–82. doi:10.1177/0952695105059306.
  • NetCord-FACT. 2019. NetCord-FACT International Standards for CORD BLOOD Collection, Banking, and Release for Administration. 7th ed. doi:10.1038/sj.bmt.1701677.
  • Nikiforow, S., S. Li, K. Snow, D. Liney, G. Kao, R. Haspel, E. Shpall, et al. 2017. “Lack of Impact of Umbilical Cord Blood Unit Processing Techniques on Clinical Outcomes in Adult Double Cord Blood Transplant Recipients.” Hematopoietic Stem Cell Transplants 19 (2): 272–284. doi:10.1016/j.jcyt.2016.10.016.
  • Politikos, I., E. Davis, M. Nhaissi, J. Wagner, C. Brunstein, S. Cohen, E. Shpall, et al. 2020. “Guidelines for Cord Blood Unit Selection.” Biology of Blood and Marrow Transplantation 26 (12): 2190–2196. doi:10.1016/j.bbmt.2020.07.030.
  • Querol, S., S. Gomez, A. Pagliuca, M. Torrabadella, and J. Madrigal. 2010. “Quality Rather Than Quantity: The Cord Blood Bank Dilemma.” Bone Marrow Transplantation 45 (6): 970–978. doi:10.1038/bmt.2010.7.
  • Rich, I. 2015. “Improving Quality and Potency Testing for Umbilical Cord Blood: A New Perspective.” Stem Cells Translational Medicine 4 (9): 967–973. doi:10.5966/sctm.2015-0036.
  • Saccardi, R., L. Tucunduva, A. Ruggeri, I. Ionescu, G. Koegler, S. Querol, G. Grazzini, et al. 2016. “Impact of Cord Blood Banking Technologies on Clinical Outcome: A Eurocord/Cord Blood Committee (CTIWP), European Society for Blood and Marrow Transplantation and NetCord Retrospective Analysis.” Transfusion 56 (8): 2021–2029. doi:10.1111/trf.13661.
  • Santos, S., S. Barros, M. Santos, L. Marti, A. Ribeiro, A. Kondo, and J. Kutner. 2016. “Predictors of High-Quality Cord Blood Units.” Transfusion 56 (8): 2030–2036. doi:10.1111/trf.13653.
  • Scaradavou, A., K. M. Smith, R. Hawke, A. Schaible, M. Abboud, N. A. Kernan, J. W. Young, and J. N. Barker. 2010. “Cord Blood Units with Low CD34+ Cell Viability Have a Low Probability of Engraftment After Double Unit Transplantation.” Biology of Bone Marrow Transplantation 16 (4): 500–508. doi:10.1016/j.bbmt.2009.11.013.
  • Shaw, B. E., P. Veys, A. Pagliuca, J. Addada, G. Cook, C. F. Craddock, A. R. Gennery, et al. 2009. “Recommendations for a Standard UK Approach to Incorporating Umbilical Cord Blood Into Clinical Transplantation Practice: Conditioning Protocols and Donor Selection Algorithms.” Bone Marrow Transplantation 44: 7–12. doi:10.1038/bmt.2008.420.
  • Sleeboom-Faulkner, M. 2011. “Regulating Cell Lives in Japan: Avoiding Scandal and Sticking to Nature.” New Genetics and Society 30 (3): 227–240. doi:10.1080/14636778.2011.598052.
  • Sleeboom-Faulkner, M., and P. K. Patra. 2011. “Experimental Stem Cell Therapy: Biohierarchies and Bionetworking in Japan and India.” Social Studies of Science 41 (5): 645–666. doi:10.1177/0306312711409792.
  • Takanashi, M., H. Tanaka, M. Kohsaki, K. Nakajima, K. Tadokoro, and M. Nakabayashi. 2011. “A Suggested Total Size for the Cord Blood Banks of Japan.” Bone Marrow Transplantation 46 (7): 1014–1015. doi:10.1038/bmt.2010.216.
  • Titmuss, R. 1970. The Gift Relationship: From Human Blood to Social Policy. London: Allen and Unwin.
  • UK Stem Cell Strategic Forum. 2010. “The Future of Unrelated Donor Stem Cell Transplantation in the UK. Part 1. Findings and Recommendations.” https://silo.tips/download/part-1-findings-and-recommendations.
  • Wagner, A., J. N. Barker, T. E. DeFor, K. S. Baker, B. R. Blazar, C. Eide, A. Goldman, et al. 2002. “Transplantation of Unrelated Donor Umbilical Cord Blood in 102 Patients with Malignant and Non-Malignant Diseases: Influence of CD34 Cell Dose and HLA Disparity on Treatment-Related Mortality and Survival.” Blood 100 (5): 1611–1618. doi:10.1182/blood-2002-01-0294.
  • Williams, R. 2015. “Cords of Collaboration: Interests and Ethnicity in the UK’s Public Stem Cell Inventory.” New Genetics and Society 34 (3): 319–337. doi:10.1080/14636778.2015.1060116.
  • Williams, R. 2018. “Bloody Infrastructures!: Exploring Challenges in Cord Blood Collection Maintenance.” Technology Analysis and Strategic Management 30 (4): 473–483. doi:10.1080/09537325.2017.1337888.
  • World Marrow Donor Association. 2020. “WMDA GLOBAL TRENDS REPORT 2020.” https://wmda.info/wp-content/uploads/2021/05/GTR-2020-Summary-slides.pdf.